{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:31:47Z","timestamp":1779114707899,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100010679","name":"Pasteur Institute of Iran","doi-asserted-by":"crossref","award":["B-8803"],"award-info":[{"award-number":["B-8803"]}],"id":[{"id":"10.13039\/501100010679","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.molimm.2015.04.015","type":"journal-article","created":{"date-parts":[[2015,5,19]],"date-time":"2015-05-19T16:03:30Z","timestamp":1432051410000},"page":"384-391","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7\/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen"],"prefix":"10.1016","volume":"66","author":[{"given":"Maryam","family":"Golshani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sima","family":"Rafati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Davar","family":"Siadat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Nejati-Moheimani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fereshteh","family":"Shahcheraghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amin","family":"Arsang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeid","family":"Bouzari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2015.04.015_bib0165","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1128\/IAI.69.8.4816-4822.2001","article-title":"Protection of BALB\/c mice against Brucella abortus 544 challenge by vaccination with Bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant","volume":"69","author":"Al-Mariri","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2015.04.015_bib0170","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1016\/S0264-410X(00)00498-9","article-title":"Adjuvants designed for veterinary and human vaccines","volume":"19","author":"Aucouturier","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2015.04.015_bib0020","doi-asserted-by":"crossref","first-page":"743509","DOI":"10.1155\/2013\/743509","article-title":"A history of the development of Brucella vaccines","volume":"2013","author":"Avila-Calder\u00f3n","year":"2013","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.molimm.2015.04.015_bib0005","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1574-6976.2012.00334.x","article-title":"Internal affairs: investigating the Brucella intracellular lifestyle","volume":"36","author":"Bargen","year":"2012","journal-title":"FEMS Microbiol. Rev."},{"issue":"4","key":"10.1016\/j.molimm.2015.04.015_bib0050","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/mt.2009.5","article-title":"Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments","volume":"17","author":"Bodles-Brakhop","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.molimm.2015.04.015_bib0150","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1084\/jem.186.10.1621","article-title":"Oligonucleotide adjuvants for T helper 1 (Th1)-specific vaccination","volume":"186","author":"Carson","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molimm.2015.04.015_bib0105","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.1128\/IAI.73.10.6537-6546.2005","article-title":"A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response","volume":"73","author":"Cassataro","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2015.04.015_bib0070","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1128\/CVI.00472-06","article-title":"Improved immunogenicity of a vaccination regimen combining a DNA vaccine encoding Brucella melitensis outer membrane protein 31(Omp31) and recombinant Omp31 boosting","volume":"14","author":"Cassataro","year":"2007","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.molimm.2015.04.015_bib0100","doi-asserted-by":"crossref","first-page":"8079","DOI":"10.1128\/IAI.73.12.8079-8088.2005","article-title":"Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection","volume":"73","author":"Cassataro","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2015.04.015_bib0115","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1016\/j.vaccine.2007.03.028","article-title":"A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination","volume":"25","author":"Cassataro","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2015.04.015_bib0135","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1128\/IAI.68.3.1450-1456.2000","article-title":"CpG oligo-deoxynucleotides act as adjuvants for pneumococcal polysaccharide-protein conjugate vaccines and enhance antipolysaccharide immunoglobulin G2a (IgG2a) and IgG3 antibodies","volume":"68","author":"Chu","year":"2000","journal-title":"Infect. Immun."},{"issue":"4","key":"10.1016\/j.molimm.2015.04.015_bib0060","doi-asserted-by":"crossref","first-page":"e19181","DOI":"10.1371\/journal.pone.0019181","article-title":"Evaluation of a novel non-penetrating electrode for use in DNA vaccination","volume":"6","author":"Donate","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.molimm.2015.04.015_bib0125","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.molimm.2015.01.009","article-title":"Vaccination with recombinant L7\/L12-Truncated Omp31 protein induces protection against Brucella infection in BALB\/c mice","volume":"65","author":"Golshani","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2015.04.015_bib0130","article-title":"In silico design, cloning and high level expression of the fusion protein encoding L7\/L12 and truncated Omp31 Brucella proteins","author":"Golshani","year":"2015","journal-title":"Res. Pharm. Sci."},{"key":"10.1016\/j.molimm.2015.04.015_bib0110","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.rvsc.2006.07.014","article-title":"Induction of immune response in mice with a DNA vaccine encoding outer membrane protein (omp31) of Brucella melitensis 16M","volume":"82","author":"Gupta","year":"2007","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.molimm.2015.04.015_bib0120","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1016\/j.vaccine.2012.04.036","article-title":"Invasive Escherichia coli vaccines expressing Brucella melitensis outer membrane proteins 31 or 16 or periplasmic protein BP26 confer protection in mice challenged with B. melitensis","volume":"30","author":"Gupta","year":"2012","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.molimm.2015.04.015_bib0055","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1128\/CVI.05045-11","article-title":"Comparison of plasmid vaccine immunization schedules using intradermal in vivo electroporation","volume":"18","author":"Hallengard","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.molimm.2015.04.015_bib0010","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2012.00002","article-title":"Analyses of Brucella pathogenesis, host immunity, and vaccine targets using systems biology and bioinformatics","author":"He","year":"2012","journal-title":"Front. Cell Infect. Microbiol."},{"key":"10.1016\/j.molimm.2015.04.015_bib0030","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1745-7580-6-S1-S5","article-title":"Bioinformatics analysis of Brucella vaccines and vaccine targets using VIOLIN","volume":"6","author":"He","year":"2010","journal-title":"Immunome Res."},{"issue":"1\u20132","key":"10.1016\/j.molimm.2015.04.015_bib0140","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jim.2007.08.004","article-title":"Hock immunization: a humane alternative to mouse footpad injections","volume":"328","author":"Kamala","year":"2007","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.molimm.2015.04.015_bib0095","first-page":"132","article-title":"Brucella abortus L7\/L12 Recombinant protein induces strong Th1 response in acute brucellosis patients","volume":"7","author":"Kazak","year":"2010","journal-title":"Iran. J. Immunol."},{"key":"10.1016\/j.molimm.2015.04.015_bib0155","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1073\/pnas.93.7.2879","article-title":"CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma","volume":"93","author":"Klinman","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molimm.2015.04.015_bib0085","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/S0264-410X(97)00140-0","article-title":"Nucleic acid vaccination of Brucella abortus ribosomal L7\/L12 gene elicits immune response","volume":"15","author":"Kurar","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2015.04.015_bib0040","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1128\/IAI.74.5.2734-2741.2006","article-title":"Protective immunity elicited by a divalent DNA vaccine encoding both the L7\/L12 and Omp16 genes of Brucella abortus in BALB\/c mice","volume":"74","author":"Luo","year":"2006","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2015.04.015_bib0045","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00029330-200602020-00012","article-title":"DNA vaccine encoding L7\/L12-P39 of Brucella abortus induces protective immunity in BALB\/c mice","volume":"119","author":"Luo","year":"2006","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.molimm.2015.04.015_bib0075","first-page":"659","article-title":"Recombinant L7\/L12 ribosomal protein and gamma-irradiated Brucella abortus induce a T-helper 1 subset response from murine CD4+ T cells","volume":"83","author":"Oliveira","year":"1994","journal-title":"Immunology"},{"issue":"9","key":"10.1016\/j.molimm.2015.04.015_bib0035","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1586\/erv.11.110","article-title":"Confronting the barriers to develop novel vaccines against brucellosis","volume":"10","author":"Oliveira","year":"2011","journal-title":"Expert Rev. Vaccines"},{"issue":"10","key":"10.1016\/j.molimm.2015.04.015_bib0080","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0264-410X(96)00018-7","article-title":"Immunization of mice with recombinant L7\/Ll2 ribosomal protein confers protection against Brucella abortus infection","volume":"14","author":"Olivera","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2015.04.015_bib0025","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1574-6976.2010.00211.x","article-title":"Towards a Brucella vaccine for humans","volume":"34","author":"Perkins","year":"2010","journal-title":"FEMS Microbiol. Rev."},{"issue":"4","key":"10.1016\/j.molimm.2015.04.015_bib0065","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0167-5699(00)01612-1","article-title":"The prime-boost strategy: exciting prospects for improved vaccination","volume":"21","author":"Ramshaw","year":"2000","journal-title":"Trends Immunol. Today"},{"key":"10.1016\/j.molimm.2015.04.015_bib0160","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nm0897-849","article-title":"Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants","volume":"3","author":"Roman","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.molimm.2015.04.015_bib0145","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1146\/annurev.iy.06.040188.001343","article-title":"Structure and function of human and murine receptors for IgG","volume":"6","author":"Unkeless","year":"1988","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.molimm.2015.04.015_bib0015","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11515-012-1196-0","article-title":"Progress in Brucella vaccine development","volume":"8","author":"Yang","year":"2012","journal-title":"Front. Biol."},{"key":"10.1016\/j.molimm.2015.04.015_bib0090","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1016\/j.vaccine.2009.06.075","article-title":"Protection of mice from Brucella infection by immunization with attenuated Salmonella enterica serovar typhimurium expressing L7\/L12 and BLS fusion antigen of Brucella","volume":"27","author":"Zhao","year":"2009","journal-title":"Vaccine"}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589015003740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589015003740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T07:09:14Z","timestamp":1589526554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589015003740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0161589015003740"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2015.04.015","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7\/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2015.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}